Related Experiment Video

Updated: Sep 27, 2026

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

[The clinical study of azithromycin in otolaryngologic infection]

M Naoya1

  • 1Department of Otolaryngology, Nagoya City University Medical School.

The Japanese Journal of Antibiotics
|February 8, 2003
PubMed

Insights

Azithromycin, a novel macrolide antibiotic, shows excellent efficacy in treating ear, nose, and throat infections. A short, 3-day azithromycin regimen provides sustained high tissue levels and effectiveness comparable to longer antibiotic courses.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Otolaryngology

Background:

  • Azithromycin is a novel macrolide antibiotic developed by Pfizer Pharmaceuticals.
  • Otolaryngologic infections require effective antibiotic treatment with good tissue penetration.

Observation:

  • Azithromycin demonstrated sustained high concentrations in tissues compared to serum levels.
  • The study evaluated azithromycin's efficacy and tissue penetration in otolaryngologic infections.

Findings:

  • A 3-day azithromycin regimen achieved excellent efficacy.
  • The efficacy of the 3-day azithromycin regimen was comparable to 10-day regimens of other antibiotics.

Implications:

  • Azithromycin is a highly useful antibiotic for treating ear, nose, and throat infections.
  • Short-course azithromycin therapy offers a convenient and effective treatment option.

Related Concept Videos

Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.